PUBLISHER: Roots Analysis | PRODUCT CODE: 1919795
PUBLISHER: Roots Analysis | PRODUCT CODE: 1919795
As per Roots Analysis, the Middle East DNA synthesis market is estimated to grow from USD 1.93 billion in the current year to USD 7.60 billion by 2035 at a CAGR of 16% during the forecast period, 2026-2035.

DNA synthesis involves the development of deoxyribonucleic acid (DNA) molecules intended for producing gene therapies and other therapeutic candidates. The growing trend towards personalized therapies tailored to individual patient needs has led to a heightened demand for DNA or RNA molecules in a wide range of therapeutic uses. In addition to therapeutic purposes, DNA molecules are essential in medical research, disease diagnosis, analytical methods, and forensic science. Numerous studies have been executed or are currently underway to assess the therapeutic potential of oligonucleotides, especially DNA, for various health conditions. Further, oligonucleotide molecules are presently being utilized in the diagnosis of genetic diseases, including cancer, ovarian cancer, dyslexia, psoriasis, and Parkinson's disease. In addition, cutting-edge technologies such as genetic engineering, genome sequencing, gel electrophoresis, DNA methylation, and recombinant DNA methods empower researchers to synthesize specific oligonucleotides for therapeutic development. Notably, various DNA-based therapies have been formulated by pharmaceutical companies to assist in disease treatment. Fueled by the rising demand for naturally or artificially produced DNA, numerous industry leaders are actively engaging in this field to streamline DNA synthesis, making it faster, more sustainable, and more accurate.
The Middle East and North Africa (MENA) DNA synthesis market commands a significant regional share due to robust government-backed genomics initiatives and surging investments in biotechnology infrastructure. Nations such as Saudi Arabia, UAE, and Qatar stimulate growth via initiatives, such as the Saudi Human Genome Program and Qatar Genome Program, which enhance the need for synthetic DNA in gene editing, NGS validation, PCR probes, and functional genomics studies. Such factors establish MENA for significant growth despite in the coming years.
Growth Drivers: Strategic Enablers of Market Expansion
The increasing focus on genomics research and national precision medicine programs in GCC nations enhances the demand for tailored DNA synthesis in the fields of synthetic biology and biomarker research. The rise of molecular diagnostics, including PCR and NGS panels for cancer and infectious diseases, fuels the need for primers and probes. Growth in the biopharmaceutical sector, contract research organizations, and healthcare research and development investments foster advances in drug discovery and therapeutic development. In addition, government support for biotechnology hubs accelerates the adoption of technology and the development of local capabilities.
Market Challenges: Critical Barriers Impeding Progress
Dependence on foreign DNA synthesis results in increased expenses, delays, and weaknesses in the supply chain. Varied regulations among MENA nations create difficulties in meeting compliance and conducting cross-border business. A lack of skilled professionals and advanced laboratory facilities hinder growth in several sectors. Financial limitations in less affluent areas prioritize simpler applications instead of intricate, high-fidelity synthesis.
Chemical Method: Leading Market Segment
In terms of method of DNA synthesis, the Middle East DNA Synthesis market is segmented across chemical and enzymatic methods. The chemical method segment is likely to hold the higher market share owing to the fact that it is a mature, well standardized technology with decades of validation, giving labs high confidence in sequence quality and reliability.
Research and Diagnostic Applications: Dominating Market Segment
In terms of key application areas, the Middle East market is segmented across Research and Diagnostic applications and therapeutic applications. Currently, majority (~65%) of the market share is held by research and diagnostic applications. Research and diagnostic applications hold the highest market share in the Middle East DNA synthesis market due to surging investments in genomics infrastructure and precision medicine initiatives
Method of DNA Synthesis
Key Application Areas
Company Size
Country
COMPLEMENTARY BENEFITS